Olymvax Biopharmaceuticals: Shanghai Wushan has reduced its holdings by 3.00%

Zhitong
2025.10.31 08:53

Olymvax Biopharmaceuticals announced that its controlling shareholder, Shanghai Wushan, originally planned to reduce its holdings by no more than 12.178 million shares through centralized bidding and block trading from August 13 to November 12, 2025. As of October 31, 4.0593 million shares were reduced through centralized bidding and 8.1187 million shares were reduced through block trading, totaling 12.178 million shares, accounting for 3.00% of the total share capital, with transaction prices ranging from 19.28 to 30.67 yuan, cashing out 279 million yuan; it currently holds 60.2163 million shares, accounting for 14.83%, and the reduction plan has been completed

Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.